Nuveen S&P 500 Buy-Write Income Fund (NYSE:BXMX – Get Free Report) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 25,600 shares, an increase of 20.8% from the November 15th total of 21,200 shares. Based on an average trading volume of 154,500 shares, the days-to-cover ratio is currently 0.2 days.
Nuveen S&P 500 Buy-Write Income Fund Price Performance
Shares of BXMX traded up $0.03 during mid-day trading on Friday, reaching $13.91. 159,822 shares of the company were exchanged, compared to its average volume of 176,446. The business has a 50 day simple moving average of $13.87 and a two-hundred day simple moving average of $13.53. Nuveen S&P 500 Buy-Write Income Fund has a 52 week low of $12.45 and a 52 week high of $14.30.
Nuveen S&P 500 Buy-Write Income Fund Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 31st. Stockholders of record on Friday, December 13th will be paid a $0.2725 dividend. This represents a $1.09 dividend on an annualized basis and a dividend yield of 7.84%. The ex-dividend date of this dividend is Friday, December 13th.
Institutional Investors Weigh In On Nuveen S&P 500 Buy-Write Income Fund
Nuveen S&P 500 Buy-Write Income Fund Company Profile
Nuveen S&P 500 Buy-Write Income Fund is a closed-ended equity indexed mutual fund launched by Nuveen Investments, Inc It is co-managed by Nuveen Fund Advisors LLC and Gateway Investment Advisers, LLC. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors.
Read More
- Five stocks we like better than Nuveen S&P 500 Buy-Write Income Fund
- What Are Some of the Best Large-Cap Stocks to Buy?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Texas Instruments: The Old-School Tech Titan Still Delivering
- The Basics of Support and Resistance
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Nuveen S&P 500 Buy-Write Income Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuveen S&P 500 Buy-Write Income Fund and related companies with MarketBeat.com's FREE daily email newsletter.